NCT00625469 Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan Status WITHDRAWN Phase PHASE4
NCT00625079 Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil Status WITHDRAWN Phase PHASE4
NCT00600028 Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide Status COMPLETED Phase PHASE3
NCT00518310 Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase NA
NCT00512967 The Occurence of Inflammation and Oxidative Stress in Lung Diseases Status COMPLETED Phase N/A
NCT00470327 A Study of the Natural Progression of Interstitial Lung Disease (ILD) Status RECRUITING Phase N/A
NCT00463983 Treatment of Idiopathic Pulmonary Fibrosis with Long Acting Octreotide Status COMPLETED Phase PHASE1/PHASE2
NCT00373841 Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) Status RECRUITING Phase N/A
NCT00287729 Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3
NCT00287716 Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3
NCT00262405 Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT00212511 Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry Status WITHDRAWN Phase N/A
NCT00203697 Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study Status UNKNOWN Phase PHASE3
NCT00189176 Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00125385 Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1